Document Type
Editorial
Publication Date
Winter 1-1-2009
Abstract
Atrial fibrillation (AF) is associated with an increased risk of mortality as well as significant morbidity including bothersome symptoms, exacerbation of heart failure, and thromboembolic events. Explanations for the mortality risk are variable, but the majority opinion favors AF as a marker of reduced health status, especially cardiovascular health.
Recommended Citation
Frisch, Daniel, "The Value of Implantable Cardioverter-Defibrillators in Managing Atrial Fibrillation" (2009). Division of Cardiology Faculty Papers. Paper 1.
https://jdc.jefferson.edu/cardiologyfp/1
